Remove 2024 Remove Diabetes Remove Prescription Filling
article thumbnail

NHC Comments on Medicare Drug Price Negotiation Program: Draft Guidance, Implementation of Sections 1191 – 1198 of the Social Security Act for Initial Price Applicability Year 2027 and Manufacturer Effectuation of the Maximum Fair Price (MFP) in 2026 and 2027

Putting Patients First Blog

Similarly, long-acting insulin analogs provide more stable blood sugar control and reduce the number of daily injections needed for diabetes patients. Findings from the Commonwealth Fund 2024 value of Medicare survey. Prior authorization and association with delayed or discontinued prescription fills. doi: 10.1002/acr.23871

article thumbnail

NHC Submits Comments to CMS RE CY 2026 Policy & Technical Changes to MA and Part D Proposed Rule

Putting Patients First Blog

The NHC recognizes that Medicare already covers AOMs for patients who are overweight and have comorbid conditions such as diabetes or cardiovascular disease. 1 (February 14, 2023): 1023, [link] 10 Institute for Clinical and Economic Review, Assessment of Barriers to Fair Access Report , 2024, [link] Report-121924.pdf. September 2021.